PRP Therapy – Your Best Shot at Rapid Healing

PRP Therapy – Your Best Shot at Rapid Healing

Did you know that the platelets in your blood not only aid clotting in case of an injury, but also facilitate healing?

Platelets are a rich source of several natural growth factors that heal wounds, repair cartilage and promote bone and tissue regeneration. Platelet-Rich Plasma (PRP) therapy uses this healing ability of the platelets to treat a number of orthopedic injuries and conditions. The procedure involves injecting platelets, taken from your blood and concentrated, into the site of pain or injury.

PRP therapy can –

  • relieve pain
  • reduce swelling
  • increase range of motion
  • improve balance and coordination
  • increase flexibility
  • accelerate post-surgical recovery

Patients that can benefit from PRP Therapy

Since PRP therapy can speed up healing, it can be utilized to treat a number of orthopedic conditions, such as –

  • Orthopedic injuries
  • Arthritis
  • Chronic Joint Pain
  • Degenerative Conditions
  • Fractures
  • Golfer’s and Tennis Elbow
  • Plantar Fasciitis
  • Strains and Sprains
  • Ligament Tears
  • Tendonitis

Many clinical studies have shown the effectiveness of PRP. The NFL (National Football League) and NBA (National Basketball Association) have found PRP to be a reasonable treatment that does not represent a performance enhancing drug. In a randomized controlled trial, where PRP was used for chronic tennis elbow, 76% patients reported success at 12 weeks in the PRP group as compared to the control group that received a steroidal injection and did not prove as effective. In addition, PRP had an 85% efficacy rate at the 2-year follow-up visit.

To learn more about regenerative therapy, such as Platelet Rich Plasma or PRP therapy in Chicago, call The Regenerative Stem Cell Institute at 855-340-7836 Now. The Regenerative Stem Cell Institute is devoted to advancing successful outcomes and quality care in the area of adult stem cell regenerative medicine.

No Comments

Sorry, the comment form is closed at this time.